Charite University, Berlin, Germany Clinical Trials
Sponsors / Charite University, Berlin, Germany
The ClinicalTrials.gov registry records 934 trials led by Charite University, Berlin, Germany. 118 trials are actively recruiting participants, 16 remain active without open enrollment, and 504 have concluded. 55 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 3,901,720 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
934
Total Trials
118
Recruiting
16
Other Active
504
Completed
55
Terminated / Withdrawn
3,901,720
Total Enrollment
Termination reasons: Recruitment47% · Other44% · Funding4% · Safety4% · Efficacy2%
Recent Terminations
- Inflammatory Cardiomyopathy"Premature end of recruitment due to lack of eligible patients. Within two years of recruitment only nine patients could be randomized out of 130 required patients as per trial protocol."
- Heart Failure with Mid-range Ejection Fraction"No extension of study funding by the DZHK following COVID-19 pandemic-induced prolongation of the recruitment period, also requiring manufacturing of further study drug batches"
- NCT04749992 Stopped Mar 2024Dream Disorder"recruitment proved to be impossible for the necessary experimental non-dreaming group"
- Chronic Low-back Pain"Sponsor did not want to continue the study."
- Fertility Disorders"Recruitment difficulties"
- Critical Illness"CE certificate ended and was not renewed"
- NCT04920734 Stopped Mar 2022Delirium"Lack of equipment"
- NCT04320082 Stopped Nov 2021Delirium"The study staff has left the clinic."
- Fatigue"Recruitment number could not be reached, difficult conditions under Corona"
- Acute Coronary Syndrome"Low recruitment rate"
Active Trials (16 total)
- NCT03381794
- NCT04607096
- NCT05897047
- NCT06874296
- NCT07529197
- NCT06459024
- Acute Myeloid Leukemia PHASE3NCT06713837
- NCT07455929
- Rheumatoid Arthritis PHASE1/PHASE2NCT06475495
- NCT06117176
- NCT06170801
- NCT03810768
- NCT07395206
- NCT06596824
- NCT07438964
- NCT04732910
- Adult Patients ≥ 18 Years PHASE2NCT06279793
- ARDS PHASE1/PHASE2NCT07193719
- NCT07418905
- NCT07290712